Leitlinien und Fachgesellschaften
European Neuroendocrine Tumor Society (ENETS) Guidelines
ENETS-Empfehlungen – Standardized Synoptic Reporting 2021/2022
- ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology
- ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors
- ENETS standardized (synoptic) reporting in neuroendocrine tumours
- ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
- ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours
- Synoptic reporting of echocardiography in carcinoid heart disease
ENETS - Standards of Care 2017
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
- ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours
- ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation
- ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine Tumors
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology: Diagnosis and Prognostic Stratification
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues
- ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Biochemical Markers
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms. Systemic Therapy 2: Chemotherapy
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents
ENETS - Guidelines 2016
- ENETS Consensus Guidelines for Neuroendocrine Neoplasms of the Appendix (Excluding Goblet Cell Carcinomas)
- ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms
- ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
- ENETS 2016 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update
- ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
- ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
- Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
- ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
- ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
NCCN Guidelines
NANETS Guidelines
2020
- The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors
- The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors
- North American Neuroendocrine Tumor Society Guide for Neuroendocrine Tumor Patient Health Care Providers During COVID-19
2018
2017
2013
- Consensus guidelines for the management and treatment of neuroendocrine tumors
- The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas
- NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus)
- The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer
- The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum
- The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the Jejunum, Ileum, Appendix, and Cecum
- NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas
- NANETS consensus guidelines for the diagnosis of neuroendocrine tumor
- The North American Neuroendocrine Tumor Society (NANETS) guidelines: mission, goals, and process
Leitlinien nationaler Fachgesellschaften
S2K-Leitlinie Neuroendokrine Tumoren – Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)
Nordic Guidelines
2021
2014
2010
Spanish Guidelines
2018
2014
2011
French Guidelines
Japanese Guidelines
Nuklearmedizinische Leitlinien
2022
2019
2018
2017
2015
2013
2010
Lebertransplantation bei NET
NEN des gynäkologischen Trakts
Pheochromocytoma | Paraglangioma Guidelines
2021
2019
- European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma
- Surgical therapy of adrenal tumors: guidelines from the German Association of Endocrine Surgeons (CAEK)
2016
2014
Multiple Endokrine Neoplasie Typ 1
2021
2012
Von-Hippel-Lindau-Sydrom
2022
2021
2013
Neurofibromatose Typ 1
2022
2021
2020
2018
Karzinoide der Lunge
2021
2020
Appendix goblet cell Adenokarzinom
Cushing | adrenal Guidelines
Leitlinienprogramm Onkologie der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. (AWMF) , der Deutschen Krebsgesellschaft e.V. (DKG) und der Deutschen Krebshilfe.
Leitlinien Komplementärmedizin, Supportive Therapie, Psychoonkologie (AWMF)
Endoskopisches Management von Neuroendokrinen Neoplasien
Covid-19 bei Patient- en/innen mit NEN